January 28, 2021 3:21pm
AGTC dived another -$0.55 or -12.47% to $3.89 after Wednesday's -0.27 or -5.72% to $4.45
AGTC offers 16.741 M shares plus an accompanying warrant to purchase 0.5 of a share of common stock issued for each share of common stock sold with a combined offering price is $4.45
Stifel, Wells Fargo Securities and MTS Health Partners are acting as joint book-running managers of the offering. H.C. Wainwright & Co. is acting as lead manager for the offering and Roth Capital Partners is acting as co-manager for the offering.
AGTC proposed includes warrants that must be exercised in integral multiples of two and will have an exercise price of $6.00 per share, will be immediately exercisable and will have a term of five years from the date of issuance.
The gross proceeds to AGTC from this offering are expected to be approximately $74.5 million
- 52-week change -35.87%
- 52-weel high of $7.40 and a low of $2.29
- Shares outstanding: 25.89 M
- Float: 21.52 M
- Share percentage (%) short of float: 4.15%
- Cash as of last Q: $66.56 M
- Total debt: $14.79 M